The thwarted ricin conspiracy serves as a stress test for India’s preparedness against biothreats, exposing regulatory blind spots and coordination deficits across security and public health systems
Image Source: Getty Images
In the first week of November 2025, a domestic terror threat came to light when a joint operation conducted by the Gujarat Anti-Terrorism Squad (ATS) discovered a plot for the production and likely usage of one of the deadliest biological toxins in the world, Ricin. Based on intelligence input regarding Dr Ahmed Mohiyuddin Saiyed, 35, from Hyderabad, the Gujarat ATS intercepted a car in the early hours of 7 November 2025 in Gujarat’s Gandhinagar district. Two Glock pistols, one Beretta pistol, 30 live cartridges, and four litres of castor oil, a material used in the process of extracting Ricin, were found in the vehicle.
Dr Saiyed and his associates were arrested and charged under the Indian Unlawful Activities (Prevention) Act, Indian Penal Code, and Arms Act. Post the vehicle interception, the doctor’s home was searched, and more materials associated with Ricin production were found, including around 3 kg of castor pulp, a waste by-product of the castor oil process; solvent acetone; a cold-press oil extraction apparatus; and a container said to be for mixing the pulp and solvent, indicative of an effort to purify ricin.
Ricin is a naturally produced toxic chemical derived from the castor plant, whose toxicity may result in severe respiratory distress, internal bleeding, and death in a short period of time. There are no antidotes for Ricin poisoning. After the arrests, the authorities reportedly handed over the confiscated goods for analysis to determine the stage of ricin toxin production and to check for any progress in the synthesis process.
The ricin case has highlighted the limits of relying on post-facto enforcement when dealing with toxins that can be prepared covertly and deployed on a small scale, producing an outsized psychological impact and eroding trust in civil stability and protection among the Indian population.
According to investigators, the accused conducted a recce of high-density areas, including markets and the offices of various organisations in Delhi, Lucknow, and Ahmedabad, to identify potential attack sites. Initial investigations have revealed that Dr Saiyed was in contact with an Afghanistan-based handler associated with the Islamic State-Khorasan Province (ISKP) and had maintained communications with other operatives from Pakistan. These interactions have been framed as part of a broader terror module combining chemical threat intent with traditional weapons.
Biological terrorism, unlike traditional terrorism threats that are gun or explosive-based, involves biological agents that lie in the grey area between chemistry, medicine, and public health. Given this, despite the minimal effort it takes to acquire these agents, the disruptiveness associated with them is relatively high. Historically, non-state actors like ISIS and Al-Qaeda have also attempted to develop biological weapons, but have failed in their actual development and deployment. ‘The ricin plot’, therefore, as this terrorism case has come to be known, was an indication of the vulnerability of the Indian biothreat system.
The Government of India’s bioterrorism-related policies have, until now, existed in a piecemeal fashion across various legislations relating to counter-terrorism law, chemical weapons, and public health preparedness measures. Legal instruments such as the Unlawful Activities (Prevention) Act (UAPA), the Chemical Weapons Convention Act, and sections of the Indian Penal Code provide the coercive backbone for prosecution, but they are primarily reactive. The ricin case has highlighted the limits of relying on post-facto enforcement when dealing with toxins that can be prepared covertly and deployed on a small scale, producing an outsized psychological impact and eroding trust in civil stability and protection among the Indian population.
Increasingly, strengthening supplier verification, improving documentation of imports and exports of dual-use materials, and enhancing inter-agency information sharing are being viewed as imperative, especially as terrorist groups continue to adapt to tighter regulations on explosive devices and weaponry.
India’s current biosafety system is framed by Department of Biotechnology guidelines and institutional ethics committees, and is primarily aimed at preventing misuse or accidental disasters rather than addressing the malicious use of biothreat materials. The dual-use nature of ricin makes clear that this framework fails to account for materials legitimately used in agriculture, medicine, and scientific research that may also be diverted for nefarious purposes. Increasingly, strengthening supplier verification, improving documentation of imports and exports of dual-use materials, and enhancing inter-agency information sharing are being viewed as imperative, especially as terrorist groups continue to adapt to tighter regulations on explosive devices and weaponry.
The forensic and public health dimensions are also of utmost significance. Responding to bioterrorism requires not only intelligence capabilities but also the swift identification of novel toxins, the tracing of transmission patterns, and the ability to distinguish between deliberate attacks and naturally occurring events. Although institutions such as DRDO laboratories, ICMR networks, and the Integrated Disease Surveillance Programme have been established in India, the ricin incident highlighted the need for expedited toxicological analysis and stronger coordination between public health institutions and security agencies to enable a prompt, unified response. In bioterrorism-related events, delays plus erroneous classification can amplify fear far beyond the actual death toll.
Further, the accused’s possession of scientific or medical credentials introduces an added layer of complexity. It calls into question the assumption that specialised expertise inherently guards against misuse and instead suggests the need to examine processes of radicalisation within professional and academic circles. Of course, this does not necessarily imply suspicion of scientists; rather, it calls for strengthened ethical instruction, sustained government support, and institutional oversight. Thus, the thwarting of bioterrorism, in many respects, becomes less an enforcement issue than a socialisation issue.
Although institutions such as DRDO laboratories, ICMR networks, and the Integrated Disease Surveillance Programme have been established in India, the ricin incident highlighted the need for expedited toxicological analysis and stronger coordination between public health institutions and security agencies to enable a prompt, unified response.
Lastly, this case has exacerbated fears of full-blown extremist networks taking advantage of regulatory gaps that exist across national borders. Biological threats, for that matter, are not constrained by national boundaries, as the absence of surveillance or enforcement in some countries may be exploited by groups operating across nations. This carries significant implications for India.
The Gujarat ATS’s thwarting of a bioterror attack using ricin may represent a rare instance that illustrates how counterterrorism frameworks often struggle to keep pace with the adaptability and ingenuity of terrorist organisations. The planned use of ricin functioned as a stress test of India’s preparedness against bioterrorism. It demonstrated that although India possesses substantial scientific expertise and considerable experience in responding to past terror attacks, biological threats require a comprehensive system that integrates intelligence capabilities with robust healthcare regulation and ethical oversight.
Shravishtha Ajaykumar is an Associate Fellow with the Centre for Security, Strategy, and Technology at the Observer Research Foundation.
The views expressed above belong to the author(s). ORF research and analyses now available on Telegram! Click here to access our curated content — blogs, longforms and interviews.
Shravishtha Ajaykumar is an Associate Fellow at the Centre for Security, Strategy, and Technology. Her research areas include Chemical, Biological, Radiological, and Nuclear (CBRN) strategy ...
Read More +
PREV
